InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →J David Enloe Jr, Chief Executive Officer, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 14 open-market SEC Form 4 transactions: 14 purchases worth $65K and 0 sales worth $0, reported from Nov 12, 21 to Aug 28, 23. Over this period they have been a net buyer.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 28, 23 | SCTLSocietal CDMO, Inc. | BUY | 125.0K | $0.40 | $50K |
| Nov 15, 22 | SCTLSocietal CDMO, Inc. | BUY | 660 | $1.71 | $1K |
| Oct 17, 22 | SCTLSocietal CDMO, Inc. | BUY | 625 | $1.69 | $1K |
| Sep 15, 22 | SCTLSocietal CDMO, Inc. | BUY | 714 | $1.41 | $1K |
| Aug 15, 22 | SCTLSocietal CDMO, Inc. | BUY | 757 | $1.26 | $954 |
| Jul 15, 22 | SCTLSocietal CDMO, Inc. | BUY | 1.1K | $0.81 | $932 |
| Jun 15, 22 | SCTLSocietal CDMO, Inc. | BUY | 1.6K | $0.68 | $1K |
| May 16, 22 | SCTLSocietal CDMO, Inc. | BUY | 1.1K | $0.96 | $1K |
| Apr 18, 22 | SCTLSocietal CDMO, Inc. | BUY | 625 | $1.63 | $1K |
| Mar 15, 22 | REPHRecro Pharma, Inc. | BUY | 512 | $1.96 | $1K |
| Feb 15, 22 | REPHRecro Pharma, Inc. | BUY | 571 | $1.77 | $1K |
| Jan 18, 22 | REPHRecro Pharma, Inc. | BUY | 602 | $1.68 | $1K |
| Dec 15, 21 | REPHRecro Pharma, Inc. | BUY | 617 | $1.61 | $993 |
| Nov 12, 21 | REPHRecro Pharma, Inc. | BUY | 1.7K | $1.68 | $3K |